Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Alimera Sciences (ALIM)
NASDAQ:ALIM
Alimera (ALIM) Stock Price & Analysis
215 Followers
ALIM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.30 - $7.92
Previous Close$1.95
Volume35.03K
Average Volume (3M)21.34K
Market Cap
$12.97M
Enterprise Value$70.81M
Total Cash (Recent Filing)$5.51M
Total Debt (Recent Filing)$44.13M
Price to Earnings (P/E)-0.7
Beta1.07
Next Earnings
Mar 31, 2023EPS Estimate
-$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.64
Shares Outstanding7,008,482
10 Day Avg. Volume12,496
30 Day Avg. Volume21,344
Standard Deviation0.22
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-0.25
Price to Sales (P/S)0.24
Price to Cash Flow (P/CF)32.80
P/FCF Ratio-1.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.31
Enterprise Value/Gross Profit1.36
Enterprise Value/Ebitda-6.98
Forecast
1Y Price Target
$9.00Price Target Upside361.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Alimera News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ALIM FAQ
What was Alimera Sciences’s price range in the past 12 months?
Alimera Sciences lowest stock price was $1.30 and its highest was $7.92 in the past 12 months.
What is Alimera Sciences’s market cap?
Currently, no data Available
When is Alimera Sciences’s upcoming earnings report date?
Alimera Sciences’s upcoming earnings report date is Mar 31, 2023 which is in 2 days.
How were Alimera Sciences’s earnings last quarter?
Alimera Sciences released its earnings results on Nov 14, 2022. The company reported -$0.75 earnings per share for the quarter, missing the consensus estimate of -$0.4 by -$0.35.
Is Alimera Sciences overvalued?
According to Wall Street analysts Alimera Sciences’s price is currently Undervalued.
Does Alimera Sciences pay dividends?
Alimera Sciences does not currently pay dividends.
What is Alimera Sciences’s EPS estimate?
Alimera Sciences’s EPS estimate is -$0.34.
How many shares outstanding does Alimera Sciences have?
Alimera Sciences has 7,008,482 shares outstanding.
What happened to Alimera Sciences’s price movement after its last earnings report?
Alimera Sciences reported an EPS of -$0.75 in its last earnings report, missing expectations of -$0.4. Following the earnings report the stock price went down -2.008%.
Which hedge fund is a major shareholder of Alimera Sciences?
Among the largest hedge funds holding Alimera Sciences’s share is Blackstone Inc.. It holds Alimera Sciences’s shares valued at N/A.
---
Alimera Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$9.00 (361.51% Upside)
$9.00 (361.51% Upside)
Blogger Sentiment
Bearish
ALIM Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 10.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $313.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.44%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-27.70%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Alimera Sciences
Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.
---
Top 5 ETFs holding ALIM
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ALIM. The ETFs are listed according to market value of ALIM within the ETF
---
Lowell Farms
―
Zynerba Pharmaceuticals
―
Real Brands
―
Angion Biomedica
―
PaxMedica, Inc.
―
---